| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.37 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |